- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Improved Synthesis of No-Carrier-Added [*I]MIBG and Its Precursor ; volume:44 ; number:21 ; year:2012 ; pages:3387-3391
Synthesis ; 44, Heft 21 (2012), 3387-3391
- Contributor
-
Hammerschmidt, Friedrich
Kvaternik, Herbert
Schweifer, Anna
Mereiter, Kurt
Aigner, Reingard M.
- DOI
-
10.1055/s-0032-1316789
- URN
-
urn:nbn:de:101:1-2019050210451178323535
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hammerschmidt, Friedrich
- Kvaternik, Herbert
- Schweifer, Anna
- Mereiter, Kurt
- Aigner, Reingard M.
Other Objects (12)
![Umpolung von nukleophilem no carrier added [18F]Fluorid zu elektrophilem no carrier added [18F]FC1O3 mit hoher spezifischer Aktivität](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Umpolung von nukleophilem no carrier added [18F]Fluorid zu elektrophilem no carrier added [18F]FC1O3 mit hoher spezifischer Aktivität
Production of non carrier added (n.c.a.) 177Lu for radiopharmaceutical applications
Impact of mediastinal, liver and lung 123I-metaiodobenzylguanidine (123I-MIBG) washout on calculated 123I-MIBG myocardial washout
Multifunctional carriers for peptide and oligonucleotide delivery by reactive precursor polymers
Neuroblastoma : mIBG in its diagnosis and management
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Improved Preparation of 3‐Oximinooxetane – An Important Precursor to Energetic Oxetanes
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Diagnose des Phäochromozytoms durch Radio-Jod-meta-Jodbenzylguanidin (MIBG)
Umpolung von nukleophilem no carrier added [18F]Fluorid zu elektrophilem no carrier added [18F]FC1O3 mit hoher spezifischer Aktivität
Production of non carrier added (n.c.a.) 177Lu for radiopharmaceutical applications
Impact of mediastinal, liver and lung 123I-metaiodobenzylguanidine (123I-MIBG) washout on calculated 123I-MIBG myocardial washout
Multifunctional carriers for peptide and oligonucleotide delivery by reactive precursor polymers
Neuroblastoma : mIBG in its diagnosis and management
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Improved Preparation of 3‐Oximinooxetane – An Important Precursor to Energetic Oxetanes
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Diagnose des Phäochromozytoms durch Radio-Jod-meta-Jodbenzylguanidin (MIBG)
Umpolung von nukleophilem no carrier added [18F]Fluorid zu elektrophilem no carrier added [18F]FC1O3 mit hoher spezifischer Aktivität
Production of non carrier added (n.c.a.) 177Lu for radiopharmaceutical applications
Impact of mediastinal, liver and lung 123I-metaiodobenzylguanidine (123I-MIBG) washout on calculated 123I-MIBG myocardial washout
Multifunctional carriers for peptide and oligonucleotide delivery by reactive precursor polymers
Neuroblastoma : mIBG in its diagnosis and management
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Improved Preparation of 3‐Oximinooxetane – An Important Precursor to Energetic Oxetanes
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma